178 related articles for article (PubMed ID: 36115189)
1. Evaluating the Social Functioning Scale modified for use in individuals at clinical high-risk for psychosis.
Kuhney FS; Damme KSF; Ellman LM; Schiffman J; Mittal VA
Schizophr Res; 2022 Oct; 248():246-253. PubMed ID: 36115189
[TBL] [Abstract][Full Text] [Related]
2. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
[TBL] [Abstract][Full Text] [Related]
3. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and Functional Consequences of Social Anxiety in Individuals at Clinical High-Risk for Psychosis: Perspective From a Community Sample Comparison.
Kuhney FS; Damme KSF; Pelletier-Baldelli A; Chun C; Ellman LM; Schiffman J; Mittal VA
Schizophr Bull Open; 2021 Jan; 2(1):sgab025. PubMed ID: 34308353
[TBL] [Abstract][Full Text] [Related]
5. Social network size in adolescents at clinical high risk for psychosis.
Ryan PC; Damme KSF; Kuhney FS; Mittal VA
Early Interv Psychiatry; 2023 May; 17(5):462-469. PubMed ID: 37156496
[TBL] [Abstract][Full Text] [Related]
6. Validation of the social functioning scale: Comparison and evaluation in early psychosis, autism spectrum disorder and social anxiety disorder.
Chan EHC; Kong SDX; Park SH; Song YJC; Demetriou EA; Pepper KL; Glozier N; Hickie IB; Guastella AJ
Psychiatry Res; 2019 Jun; 276():45-55. PubMed ID: 31004830
[TBL] [Abstract][Full Text] [Related]
7. First-rank symptoms and premorbid adjustment in young individuals at increased risk of developing psychosis.
Morcillo C; Stochl J; Russo DA; Zambrana A; Ratnayake N; Jones PB; Perez J
Psychopathology; 2015; 48(2):120-6. PubMed ID: 25720419
[TBL] [Abstract][Full Text] [Related]
8. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
[TBL] [Abstract][Full Text] [Related]
9. Alterations in facial expressivity in youth at clinical high-risk for psychosis.
Gupta T; Haase CM; Strauss GP; Cohen AS; Mittal VA
J Abnorm Psychol; 2019 May; 128(4):341-351. PubMed ID: 30869926
[TBL] [Abstract][Full Text] [Related]
10. The role of a family history of psychosis for youth at clinical high risk of psychosis.
Georgopoulos G; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
Early Interv Psychiatry; 2019 Apr; 13(2):251-256. PubMed ID: 28792113
[TBL] [Abstract][Full Text] [Related]
11. Prospective study of cannabis use in adolescents at clinical high risk for psychosis: impact on conversion to psychosis and functional outcome.
Auther AM; McLaughlin D; Carrión RE; Nagachandran P; Correll CU; Cornblatt BA
Psychol Med; 2012 Dec; 42(12):2485-97. PubMed ID: 22716931
[TBL] [Abstract][Full Text] [Related]
12. Anxiety in youth at clinical high risk for psychosis.
McAusland L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
Early Interv Psychiatry; 2017 Dec; 11(6):480-487. PubMed ID: 26456932
[TBL] [Abstract][Full Text] [Related]
13. Modeling the role of negative symptoms in determining social functioning in individuals at clinical high risk of psychosis.
Schlosser DA; Campellone TR; Biagianti B; Delucchi KL; Gard DE; Fulford D; Stuart BK; Fisher M; Loewy RL; Vinogradov S
Schizophr Res; 2015 Dec; 169(1-3):204-208. PubMed ID: 26530628
[TBL] [Abstract][Full Text] [Related]
14. Two-year follow-up of a Chinese sample at clinical high risk for psychosis: timeline of symptoms, help-seeking and conversion.
Zhang TH; Li HJ; Woodberry KA; Xu LH; Tang YY; Guo Q; Cui HR; Liu XH; Chow A; Li CB; Jiang KD; Xiao ZP; Seidman LJ; Wang JJ
Epidemiol Psychiatr Sci; 2017 Jun; 26(3):287-298. PubMed ID: 27056022
[TBL] [Abstract][Full Text] [Related]
15. Predictors of a clinical high risk status among individuals with a family history of psychosis.
Stowkowy J; Addington J
Schizophr Res; 2013 Jul; 147(2-3):281-6. PubMed ID: 23611242
[TBL] [Abstract][Full Text] [Related]
16. Association of Structural Magnetic Resonance Imaging Measures With Psychosis Onset in Individuals at Clinical High Risk for Developing Psychosis: An ENIGMA Working Group Mega-analysis.
; Jalbrzikowski M; Hayes RA; Wood SJ; Nordholm D; Zhou JH; Fusar-Poli P; Uhlhaas PJ; Takahashi T; Sugranyes G; Kwak YB; Mathalon DH; Katagiri N; Hooker CI; Smigielski L; Colibazzi T; Via E; Tang J; Koike S; Rasser PE; Michel C; Lebedeva I; Hegelstad WTV; de la Fuente-Sandoval C; Waltz JA; Mizrahi R; Corcoran CM; Resch F; Tamnes CK; Haas SS; Lemmers-Jansen ILJ; Agartz I; Allen P; Amminger GP; Andreassen OA; Atkinson K; Bachman P; Baeza I; Baldwin H; Bartholomeusz CF; Borgwardt S; Catalano S; Chee MWL; Chen X; Cho KIK; Cooper RE; Cropley VL; Dolz M; Ebdrup BH; Fortea A; Glenthøj LB; Glenthøj BY; de Haan L; Hamilton HK; Harris MA; Haut KM; He Y; Heekeren K; Heinz A; Hubl D; Hwang WJ; Kaess M; Kasai K; Kim M; Kindler J; Klaunig MJ; Koppel A; Kristensen TD; Kwon JS; Lawrie SM; Lee J; León-Ortiz P; Lin A; Loewy RL; Ma X; McGorry P; McGuire P; Mizuno M; Møller P; Moncada-Habib T; Muñoz-Samons D; Nelson B; Nemoto T; Nordentoft M; Omelchenko MA; Oppedal K; Ouyang L; Pantelis C; Pariente JC; Raghava JM; Reyes-Madrigal F; Roach BJ; Røssberg JI; Rössler W; Salisbury DF; Sasabayashi D; Schall U; Schiffman J; Schlagenhauf F; Schmidt A; Sørensen ME; Suzuki M; Theodoridou A; Tomyshev AS; Tor J; Værnes TG; Velakoulis D; Venegoni GD; Vinogradov S; Wenneberg C; Westlye LT; Yamasue H; Yuan L; Yung AR; van Amelsvoort TAMJ; Turner JA; van Erp TGM; Thompson PM; Hernaus D
JAMA Psychiatry; 2021 Jul; 78(7):753-766. PubMed ID: 33950164
[TBL] [Abstract][Full Text] [Related]
17. The reliability and validity of the revised Green et al. paranoid thoughts scale in individuals at clinical high-risk for psychosis.
Williams TF; Walker EF; Strauss GP; Woods SW; Powers AR; Corlett PR; Schiffman J; Waltz JA; Gold JM; Silverstein SM; Ellman LM; Zinbarg RE; Mittal VA
Acta Psychiatr Scand; 2023 Jun; 147(6):623-633. PubMed ID: 36905387
[TBL] [Abstract][Full Text] [Related]
18. Patterns of premorbid functioning in individuals at clinical high risk of psychosis.
Lyngberg K; Buchy L; Liu L; Perkins D; Woods S; Addington J
Schizophr Res; 2015 Dec; 169(1-3):209-213. PubMed ID: 26589390
[TBL] [Abstract][Full Text] [Related]
19. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study.
Seidman LJ; Shapiro DI; Stone WS; Woodberry KA; Ronzio A; Cornblatt BA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW
JAMA Psychiatry; 2016 Dec; 73(12):1239-1248. PubMed ID: 27806157
[TBL] [Abstract][Full Text] [Related]
20. Sensorimotor and Activity Psychosis-Risk (SMAP-R) Scale: An Exploration of Scale Structure With Replication and Validation.
Damme KSF; Schiffman J; Ellman LM; Mittal VA
Schizophr Bull; 2021 Mar; 47(2):332-343. PubMed ID: 33047134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
